RZ358 Treatment for Congenital Hyperinsulinism

Clinical trial NCT06208215 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06208215
Sponsor: Rezolute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Hyperinsulinism

Start date: 2024-01-11
Primary completion: 2025-11-14
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.